Last reviewed · How we verify
Hypertriglyceridemia
Approved treatments
- Caduet · Pfizer Inc.
Calcium channel antagonist inhibiting transmembrane calcium influx into vascular and cardiac muscle. - Inosital
Inosital works by influencing the metabolism of lipids in the body. - Niaspan · Medpointe Pharm Hlc
- Epanova · AstraZeneca
- Lipanor · Winthrop Pharmaceuticals UK Limited
- Niaspan · Cedars-Sinai Medical Center
- Lipitor · Pfizer Inc.
Selective competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. - Zocor · Merck & Co.
- Vascepa · University of Louisville
- Myoinositol · University of Colorado, Denver
- omega · Gachon University Gil Medical Center
- Nicotinic Acid · MEDPOINTE PHARM HLC
- Lopid · Pfizer
- Tricor (Micronized) · Salix
Fenofibrate activates PPARα, enhancing lipolysis and reducing triglycerides, while increasing HDL-cholesterol and uric acid excretion. - Crestor · AstraZeneca
Rosuvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme converting HMG-CoA to mevalonate, a cholesterol precursor. - Lipitor · Pfizer
Lipitor is a selective, competitive inhibitor of HMG-CoA reductase, a key enzyme in cholesterol synthesis. - Vascepa · Amarin Pharms
- Trilipix · AbbVie
- Mevacor · Merck & Co.
Mevacor works by inhibiting the enzyme HMG-CoA reductase, which plays a key role in cholesterol production in the liver. - Epanova · AstraZeneca
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hypertriglyceridemia patent landscape — cliff calendar, originator estates, attackable patents
- Hypertriglyceridemia treatment landscape brief
- Hypertriglyceridemia treatment updates RSS
Frequently asked questions about Hypertriglyceridemia
What drugs treat Hypertriglyceridemia?
Tracked treatments include Caduet, Inosital, Niaspan, Epanova, Lipanor, Lipitor, Zocor, Vascepa.
What is the treatment for Hypertriglyceridemia?
Standard treatment for Hypertriglyceridemia includes Caduet, Inosital, Niaspan, Epanova, Lipanor. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hypertriglyceridemia patent cliff · Hypertriglyceridemia CI report
- Treatment: Caduet · Pfizer Inc.
- Treatment: Inosital
- Treatment: Niaspan · Medpointe Pharm Hlc
- Treatment: Epanova · AstraZeneca
- Treatment: Lipanor · Winthrop Pharmaceuticals UK Limited
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing